Microcrystalline Cellulose (MCC) Market Size, Share, and Trends 2024 to 2034

The global microcrystalline cellulose (MCC) market size surpassed USD 1.30 billion in 2023 and is estimated to increase from USD 1.39 billion in 2024 to approximately USD 2.75 billion by 2034. It is projected to grow at a CAGR of 7.04% from 2024 to 2034.

  • Last Updated : September 2024
  • Report Code : 4916
  • Category : Chemical and Material

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Microcrystalline Cellulose (MCC) Market 

5.1. COVID-19 Landscape: Microcrystalline Cellulose (MCC) Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Microcrystalline Cellulose (MCC) Market, By Application

8.1. Microcrystalline Cellulose (MCC) Market, by Application, 2024-2034

8.1.1. Food & Beverage

8.1.1.1. Market Revenue and Forecast (2021-2034)

8.1.2. Cosmetics & Personal Care

8.1.2.1. Market Revenue and Forecast (2021-2034)

8.1.3. Pharmaceutical

8.1.3.1. Market Revenue and Forecast (2021-2034)

8.1.4. Others

8.1.4.1. Market Revenue and Forecast (2021-2034)

Chapter 9. Global Microcrystalline Cellulose (MCC) Market, By Source Type

9.1. Microcrystalline Cellulose (MCC) Market, by Source Type, 2024-2034

9.1.1. Non-Wood Based

9.1.1.1. Market Revenue and Forecast (2021-2034)

9.1.2. Wood-Based

9.1.2.1. Market Revenue and Forecast (2021-2034)

Chapter 10. Global Microcrystalline Cellulose (MCC) Market, Regional Estimates and Trend Forecast

10.1. North America

10.1.1. Market Revenue and Forecast, by Application (2021-2034)

10.1.2. Market Revenue and Forecast, by Source Type (2021-2034)

10.1.3. U.S.

10.1.3.1. Market Revenue and Forecast, by Application (2021-2034)

10.1.3.2. Market Revenue and Forecast, by Source Type (2021-2034)

10.1.4. Rest of North America

10.1.4.1. Market Revenue and Forecast, by Application (2021-2034)

10.1.4.2. Market Revenue and Forecast, by Source Type (2021-2034)

10.2. Europe

10.2.1. Market Revenue and Forecast, by Application (2021-2034)

10.2.2. Market Revenue and Forecast, by Source Type (2021-2034)

10.2.3. UK

10.2.3.1. Market Revenue and Forecast, by Application (2021-2034)

10.2.3.2. Market Revenue and Forecast, by Source Type (2021-2034)

10.2.4. Germany

10.2.4.1. Market Revenue and Forecast, by Application (2021-2034)

10.2.4.2. Market Revenue and Forecast, by Source Type (2021-2034)

10.2.5. France

10.2.5.1. Market Revenue and Forecast, by Application (2021-2034)

10.2.5.2. Market Revenue and Forecast, by Source Type (2021-2034)

10.2.6. Rest of Europe

10.2.6.1. Market Revenue and Forecast, by Application (2021-2034)

10.2.6.2. Market Revenue and Forecast, by Source Type (2021-2034)

10.3. APAC

10.3.1. Market Revenue and Forecast, by Application (2021-2034)

10.3.2. Market Revenue and Forecast, by Source Type (2021-2034)

10.3.3. India

10.3.3.1. Market Revenue and Forecast, by Application (2021-2034)

10.3.3.2. Market Revenue and Forecast, by Source Type (2021-2034)

10.3.4. China

10.3.4.1. Market Revenue and Forecast, by Application (2021-2034)

10.3.4.2. Market Revenue and Forecast, by Source Type (2021-2034)

10.3.5. Japan

10.3.5.1. Market Revenue and Forecast, by Application (2021-2034)

10.3.5.2. Market Revenue and Forecast, by Source Type (2021-2034)

10.3.6. Rest of APAC

10.3.6.1. Market Revenue and Forecast, by Application (2021-2034)

10.3.6.2. Market Revenue and Forecast, by Source Type (2021-2034)

10.4. MEA

10.4.1. Market Revenue and Forecast, by Application (2021-2034)

10.4.2. Market Revenue and Forecast, by Source Type (2021-2034)

10.4.3. GCC

10.4.3.1. Market Revenue and Forecast, by Application (2021-2034)

10.4.3.2. Market Revenue and Forecast, by Source Type (2021-2034)

10.4.4. North Africa

10.4.4.1. Market Revenue and Forecast, by Application (2021-2034)

10.4.4.2. Market Revenue and Forecast, by Source Type (2021-2034)

10.4.5. South Africa

10.4.5.1. Market Revenue and Forecast, by Application (2021-2034)

10.4.5.2. Market Revenue and Forecast, by Source Type (2021-2034)

10.4.6. Rest of MEA

10.4.6.1. Market Revenue and Forecast, by Application (2021-2034)

10.4.6.2. Market Revenue and Forecast, by Source Type (2021-2034)

10.5. Latin America

10.5.1. Market Revenue and Forecast, by Application (2021-2034)

10.5.2. Market Revenue and Forecast, by Source Type (2021-2034)

10.5.3. Brazil

10.5.3.1. Market Revenue and Forecast, by Application (2021-2034)

10.5.3.2. Market Revenue and Forecast, by Source Type (2021-2034)

10.5.4. Rest of LATAM

10.5.4.1. Market Revenue and Forecast, by Application (2021-2034)

10.5.4.2. Market Revenue and Forecast, by Source Type (2021-2034)

Chapter 11. Company Profiles

11.1. DuPont de Nemours, Inc

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. Asahi Kasei Corporation

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. DFE Pharma

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. J. RETTENMAIER & SÖHNE GmbH + Co KG

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. Recent Initiatives

11.5. Roquette Frères S.A.

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client